Wound catheter infusion after abdominal surgery in baby's.
- Conditions
- MedDRA version: 20.1Level: PTClassification code 10062022Term: Intestinal atresiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersChildren < 1 year of age undergoing major open abdominal surgery.MedDRA version: 20.1Level: PTClassification code 10021298Term: Ileal atresiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.1Level: PTClassification code 10010526Term: Congenital large intestinal atresiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.1Level: PTClassification code 10002120Term: Anal atresiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.1Level: PTClassification code 10010626Term: Congenital small intestinal atresiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.1Level: PTClassification code 10013812Term: Duodenal atresiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.1Level: PTClassification code 10028210Term: Multiple gastrointestinal atresiasSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Registration Number
- EUCTR2015-002209-12-NL
- Lead Sponsor
- Erasmus MC-Sophia Children's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 60
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
-Informed consent
-Children < 1 year of age
-Minimal post-conceptual age of 35 weeks
-Minimal body weight of 1500 grams
-Abdominal (open) surgery
Are the trial subjects under 18? yes
Number of subjects for this age range: 60
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
A potential subject who meets any of the following criteria will be excluded from participation in this study:
-Withdrawal of informed consent
-Child with neurological disease, renal or hepatic dysfunction
-Chronic (more than one day) opioid or psychotropic drug (e.g. antiepileptics, benzodiazepines, antidepressants) exposure pre- or postnatal, in neonates (maximum 28 days old) presenting for surgery, or < 1 month ago.
-Opioid exposure <24 hours before surgery
-Receiving ECMO therapy
-Known allergy / intolerance for paracetamol or morphine
-Contra-indications for regional analgesia techniques:
oAllergy to local anesthetics
oLocal or general infection (sepsis)
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method